<- Go Home
HemoSense, Inc.
HemoSense, Inc. was acquired by Alere Inc. HemoSense, Inc. develops, manufactures, and sells handheld blood coagulation monitoring systems for the management of warfarin medications for patients and healthcare professionals. The company offers INRatio System that measures the patient's blood clotting time to ensure that patients with a propensity to form clots are maintained within the therapeutic range with the proper dosage of oral anticoagulant therapy. The company offers its products through distributor partners. HemoSense, Inc. was formerly known as CardioSense, Inc. and changed its name to HemoSense, Inc. in 1998. The company was founded in 1997 and is based in San Jose, California.
Market Cap
$232.5M
Volume
21.9K
Cash and Equivalents
$3.8M
EBITDA
-$4.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$11.2M
Profit Margin
39.71%
52 Week High
$19.83
52 Week Low
$3.51
Dividend
N/A
Price / Book Value
17.44
Price / Earnings
-33.97
Price / Tangible Book Value
17.83
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$5.2M
Return on Equity
51.88%
Return on Assets
-14.19
Cash and Short Term Investments
$16.2M
Debt
$8.3M
Equity
$13.3M
Revenue
$28.1M
Unlevered FCF
-$4.0M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium